Center for Precision Health Welcomes New Faculty Leaders
The Center for Precision Health (CPH) has announced the addition of 10 faculty members. CPH is a collaborative effort between Duke CTSI and the Precision Genomics Collaboratory (PGC) that works to harness the power of genomic, biomarker, and health data to transform patient care and population health.
Duke Kannapolis Community Registry Marks Milestone with Industry License
Personal Genome Diagnostics is the first company to obtain a license to materials from a unique community registry and biorepository managed by Duke CTSI.
The license marks a milestone for the MURDOCK Study, a longitudinal population health research program that enrolled its first participant in 2009. The registry and biorepository include samples and associated data from over 12,000 participants, based at CTSI’s Duke Kannapolis research site, now a part of the new Center for Precision Health (CPH).
Svati Shah Named Associate Dean for Translational Research
The Duke University School of Medicine has announced that Svati H. Shah, MD, MS, MHS, has been named associate dean for translational research, effective immediately. Shah directs the Duke Center for Precision Health, a collaborative effort between CTSI and the Precision Genomics Collaboratory that includes CTSI’s research site at Duke Kannapolis and the OneDukeGen initiative.
Duke CTSI Presents 2023 Translational Impact Report
Duke CTSI is pleased to present the 2023 CTSI Translational Impact Report, Partnering to Improve Health, Trust, and Equity in our Communities.
Duke School of Nursing, CTSI Collaborate to Advance Research in Health Equity
Through a collaboration designed to advance research in health equity and social drivers of health, the Duke Clinical and Translational Science Institute (CTSI) and the Center for Precision Health have partnered with the Center for Nursing Research at the Duke University School of Nursing (DUSON) to bring more than 20,000 biological samples and linked data from a community-based registry at Duke Kannapolis to investigators at DUSON.
Duke Ortho, CTSI Launch Five-Year Pain Study
The Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk) project will build on a successful pilot study completed by Duke Ortho and CTSI in August. Like the pilot, recruitment for the BACk study will take place in Durham and Kannapolis, where CTSI operates the Duke Kannapolis research site on the North Carolina Research Campus.
Duke Kannapolis COVID-19 Study Illuminates Factors Surrounding Vaccination
Analysis of a COVID-19 research study based at CTSI’s Duke Kannapolis site found that education level, household income, and baseline intention were associated with longer times to vaccination, and the most common reasons for not being vaccinated were safety concerns, side effects, and vaccine effectiveness.
Kanecia Zimmerman, Joe McClernon Named CTSI Faculty Associate Directors
The Duke CTSI is proud to announce the appointment of Kanecia Zimmerman, MD, PhD, MPH, and Joe McClernon, PhD as faculty associate directors of the CTSI. Zimmerman will serve as the associate director of Engagement and Health Translation, and McClernon will serve as the associate director of Partnerships and Integration.
New Center for Precision Health Aims to Transform Population Health, Patient Care
The Duke Clinical and Translational Science Institute (CTSI) is pleased to announce the launch of the Center for Precision Health (CPH), a collaboration that will harness the power of genomic, biomarker, and health data to transform patient care and population health.
Duke Diabetes Researchers Use MURDOCK Study to Find Markers for Fracture Risk
Samples and data from the MURDOCK Study helped Duke University researchers identify new indicators of fracture risk among older adults with type 2 diabetes.